CD8A and myeloid sarcoma: By contrast, there were fewer CD8+ Treg (identified as CD8+CD25+FoxP3+ cells) in the CSF than in the peripheral blood of MS patients in relapse [115], suggesting a decrease in these regulatory cells at sites of local inflammation.